Claudia Ramos
Overview
Explore the profile of Claudia Ramos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ribeiro Ferreira V, Brayne C, Ragonese P, Ketzoian C, Piccioli M, Tinti L, et al.
J Neurol
. 2024 Feb;
271(5):2694-2703.
PMID: 38378908
Background: Most neurological diseases have no curative treatment; therefore, focusing on prevention is key. Continuous research to uncover the protective and risk factors associated with different neurological diseases is crucial...
2.
How does sensitivity influence early executive function? A critical review on hot and cool processes
Ramos C, Pereira A, Feher A, Baptista J
Infant Behav Dev
. 2023 Oct;
73:101895.
PMID: 37856950
There is compelling evidence that the quality of caregiver-child interactions during toddlerhood and the preschool years supports the development of executive function (EF) (Bernier et al., 2010; 2015; 2016; Fay-Stammbach...
3.
Ramos C, Madrigal C, Aguirre-Acevedo D, Giraldo-Chica M, Acosta-Baena N, Aponte C, et al.
J Alzheimers Dis
. 2023 Aug;
95(3):1091-1106.
PMID: 37638430
Background: The SARS-CoV2 global pandemic impacted participants in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease (ADAD) clinical trial, who faced three stressors: 1) fear of developing dementia; 2)...
4.
Lopera F, Custodio N, Rico-Restrepo M, Allegri R, Barrientos J, Garcia Batres E, et al.
Front Neurol
. 2023 Jul;
14:1198869.
PMID: 37497015
Alzheimer's disease (AD) represents a substantial burden to patients, their caregivers, health systems, and society in Latin America and the Caribbean (LAC). This impact is exacerbated by limited access to...
5.
Toscano C, Lopes P, Ramos C, Baptista J
Child Indic Res
. 2022 Aug;
16(1):69-85.
PMID: 36035772
The COVID-19 pandemic has led to significant changes in the lives of families with young children. The present study aimed to explore whether child social isolation due to the COVID-19...
6.
Ramos C, Cabral E, Serrao V, Figueira P, Santos P, Baptista J
J Child Adolesc Trauma
. 2022 Aug;
15(3):627-637.
PMID: 35958709
The UCLA PTSD Reaction Index for DSM-5 (RI-5) is a developmentally appropriate and well recognized screening tool for the assessment of Post-Traumatic Stress Disorder (PTSD) in children and adolescents. The...
7.
Ramos C, Villalba C, Garcia J, Lanata S, Lopez H, Aguillon D, et al.
J Alzheimers Dis
. 2021 Dec;
85(4):1423-1439.
PMID: 34924385
Background: Cigarette smoking is a known risk factor for Alzheimer's disease (AD). However, the association between neurodegeneration and other substances has not been fully determined. It is of vital importance...
8.
Parra M, Baez S, Sedeno L, Gonzalez Campo C, Santamaria-Garcia H, Aprahamian I, et al.
Alzheimers Dement
. 2021 Feb;
17(2):295-313.
PMID: 33634602
Across Latin American and Caribbean countries (LACs), the fight against dementia faces pressing challenges, such as heterogeneity, diversity, political instability, and socioeconomic disparities. These can be addressed more effectively in...
9.
Sanchez J, Hanseeuw B, Lopera F, Sperling R, Baena A, Bocanegra Y, et al.
Alzheimers Res Ther
. 2021 Jan;
13(1):27.
PMID: 33451357
Background: Neuroimaging studies of autosomal dominant Alzheimer's disease (ADAD) enable characterization of the trajectories of cerebral amyloid-β (Aβ) and tau accumulation in the decades prior to clinical symptom onset. Longitudinal...
10.
Ramos C, Aguillon D, Cordano C, Lopera F
Dement Neuropsychol
. 2020 Sep;
14(3):223-236.
PMID: 32973976
Alzheimer's disease (AD) and frontotemporal dementia (FTD) are neurodegenerative disorders that result in a significant burden to both patients and caregivers. By 2050, the number of people with dementia in...